Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro

Oncogene

Volumn 23, Issue 42, 2004, Pages 6997-7004

  Abedini, Mohammad R ^a,b   Qiu, Qing ^a,b   Yan, Xiaojuan ^a,b   Tsang, Benjamin K ^a,b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c NONE   (Canada)

Author keywords

Caspases; Chemoresistance; Cisplatin; FLIP; Ovarian cancer

Indexed keywords

CASPASE 3; CASPASE 8; CISPLATIN; COMPLEMENTARY DNA; FLICE INHIBITORY PROTEIN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN TARGETING;

CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 3; CASPASE 8; CASPASES; CELL LINE, TUMOR; CISPLATIN; DNA, COMPLEMENTARY; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; OVARIAN NEOPLASMS; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 4844220794     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207925     Document Type: Article

References (31)

1. Arts HJ, Van Der Zee AG, De Jong S and De Vries EG. (2000). Int. J. Gynecol. Cancer, 10, 47-52.
2. Asselin E, Mills GB and Tsang BK. (2001). Cancer Res., 61, 1862-1868.
3. Barry MA, Behnke CA and Eastman A. (1990). Biochem Pharmacol., 40, 2353-2362.
4. Bin L, Li X, Xu LG and Shu HB. (2002). FEBS Lett., 510, 37-40.
5. Cheng JQ, Jiang X, Fraser M, Li M, Dan HC, Sun M and Tsang BK. (2002). Drug Resist. Updat., 5, 131-146.
6. Delmastro DA, Li J, Vaisman A, Solle M and Chaney SG. (1997). Cancer Chemother. Pharmacol., 39, 245-253.
7. Eastman A. (1986). Biochemistry, 25, 3912-3915.
8. Fichtinger-Schepman AM, van der Veer JL, den Hartog JH, Lohman PH and Reedijk J. (1985). Biochemistry, 24, 707-713.
9. Fraser M, Leung BM, Van X, Dan HC, Cheng JQ and Tsang BK. (2003). Cancer Res., 63, 7081-7088.
10. Fukazawa T, Fujiwara T, Uno F, Teraishi F, Kadowaki Y, Itoshima T, Takata Y, Kagawa S, Roth JA, Tschopp J and Tanaka N. (2001). Oncogene, 20, 5225-5231.
11. Hennino A, Berard M, Casamayor-Palleja M, Krammer PH and Defrance T. (2000). J. Immunol., 165, 3023-3030.
12. Hu L, Hofmann J, Lu Y, Mills GB and Jaffe RB. (2002). Cancer Res., 62, 1087-1092.
13. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE and Tschopp J. (1997). Nature, 388, 190-195.
14. Kamarajan P, Sun NK and Chao CC. (2003). Biochem. J., 376, 253-260.
15. Kamsteeg M, Rutherford T, Sapi E, Hanczaruk B, Shahabi S, Flick M, Brown D and Mor G. (2003). Oncogene, 22, 2611-2620.
16. Kim JH, Ajaz M, Lokshin A and Lee YJ. (2003). Clin. Cancer Res., 9, 3134-3141.
17. Kinoshita H, Yoshikawa H, Shiiki K, Hamada Y, Nakajima Y and Tasaka K. (2000). Int. J. Cancer, 88, 986-991.
18. Kirchhoff S, Muller WW, Krueger A, Schmitz I and Krammer PH. (2000). J. Immunol., 165, 6293-6300.
19. Krueger A, Baumann S, Krammer PH and Kirchhoff S. (2001). Mol. Cell. Biol., 21, 8247-8254.
20. Li J, Feng Q, Kim JM, Schneiderman D, Liston P, Li M, Vanderhyden B, Faught W, Fung MF, Senterman M, Korneluk RG and Tsang BK. (2001). Endocrinology, 142, 370-380.
21. Ryu BK, Lee MG, Chi SG, Kim YW and Park JH. (2001). J. Pathol., 194, 15-19.
22. Sasaki H, Sheng Y, Kotsuji F and Tsang BK. (2000). Cancer Res., 60, 5659-5666.
23. Schneiderman D, Kim JM, Senterman M and Tsang BK. (1999). Apoptosis, 4, 271-281.
24. Song JH, Song DK, Herlyn M, Petruk KC and Hao C. (2003). Clin. Cancer Res., 9, 4255-4266.
25. Vignati S, Codegoni A, Polato F and Broggini M. (2002). Eur. J. Cancer, 38, 177-183.
26. Wajant H. (2003). Mol. Interv., 3, 124-127.
27. Wang J, Lobito AA, Shen F, Hornung F, Winoto A and Lenardo MJ. (2000). Eur. J. Immunol., 30, 155-163.
28. Xiao CW, Yan X, Li Y, Reddy SA and Tsang BK. (2003). Endocrinology, 144, 623-630.
29. Yang BF, Xiao C, Roa WH, Krammer PH and Hao C. (2003). J. Biol. Chem., 278, 7043-7050.
30. Yoshikawa H, Nakajima Y and Tasaka K. (2000). J. Immunol., 165, 6262-6269.
31. Yuan ZQ, Feldman RI, Sussman GE, Coppola D, Nicosia SV and Cheng JQ. (2003). J. Biol. Chem., 278, 23432-23440.